G1 Therapeutics Competitors and Similar CompaniesClear all

G1 Therapeutics's competitors and similar companies include Kadmon, Zyngenia, Bluebird Bio and Kite Pharma.
G1 Therapeutics
G1 Therapeutics
G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
Kadmon
Kadmon
Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.
Zyngenia
Zyngenia
Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways.
Bluebird Bio
Bluebird Bio
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
Kite Pharma
Kite Pharma
Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.
Founding Date
Founding Date
2008
Founding Date
2010
Founding Date
2009
Founding Date
1992
Founding Date
2009
Type
Type
Public
Type
Subsidiary
Type
Private
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Durham, US HQ
Locations
New York, US HQ
Cambridge, US
South Brunswick Township, US
Warrendale, US
Locations
Washington, US HQ
Locations
Somerville, US HQ
Locations
Santa Monica, US HQ
Hoofddorp, NL
London, GB
El Segundo, US
Emeryville, US
Frederick, US
Oceanside, US
see more
Employees
Employees
17015% increase
Employees
1151% decrease
Employees
N/A
Employees
32338% decrease
Employees
4,0511% decrease
Valuation ($)
Valuation ($)
244.3 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
212 m
Valuation ($)
N/A
Twitter followers
Twitter followers
1.3 k
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
10.6 k
Twitter followers
5.1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
3
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
0.4
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.1
Average likes per tweet (last 30 days)
8.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
40%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
100%

Financial

Revenue (est.)
Revenue (est.)
$82.5m (FY, 2023)
Revenue (est.)
$8.3m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
$3.6m (FY, 2022)
Revenue (est.)
N/A
Net income
Net income
($48m) (FY, 2023)
Net income
($108.9m) (FY, 2020)
Net income
N/A
Net income
($266.6m) (FY, 2022)
Net income
N/A

Operating

Patents and Patent Applications
Patents and Patent Applications
350 (FY, 2020)
Patents and Patent Applications
N/A
Patents and Patent Applications
N/A
Patents and Patent Applications
1.2 k (FY, 2020)
Patents and Patent Applications
N/A

Funding

Total funding raised
Total funding raised
$ 289.6m
Total funding raised
$ 21.3m
Total funding raised
$ 25m
Total funding raised
$ 409m
Total funding raised
$ 85.3m
For sources of this data, please see the company profile

View Company Profiles

Kadmon
HQ
New York, US

Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.

View company
Zyngenia
HQ
Washington, US

Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways.

View company
Bluebird Bio
HQ
Somerville, US
Employees
323↓ 38% decrease

Bluebird Bio is a developer of gene therapies for severe genetic diseases.

View company
Kite Pharma
HQ
Santa Monica, US

Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.

View company